RT Journal Article
SR Electronic
T1 561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A640
OP A640
DO 10.1136/jitc-2023-SITC2023.0561
VO 11
IS Suppl 1
A1 Revach, Or-Yam
A1 Cicerchia, Angelina
A1 Sade-Feldman, Moshe
A1 Anderson, Seth
A1 Petrova, Boryana
A1 Shorer, Ofir
A1 Bod, Lloyd
A1 Mehta, Arnav
A1 Cattaneo, Giulia
A1 Tiwari, Payal
A1 Sharova, Tatyana
A1 Xie, Hongyan
A1 Michaud, William
A1 Rasmussen, Martin
A1 Fang, Jacy
A1 Ferrone, Soldano
A1 Flaherty, Keith
A1 Boland, Genevieve M
A1 Sen, Debattama R
A1 Yizhak, Keren
A1 Kanarek, Naama
A1 Manguso, Robert T
A1 Hacohen, Nir
A1 Jenkins, Russell
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A640.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.